List of SBIR/STTR awards granted to Biostream Therapeutics, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Biostream Therapeutics, Inc. for $103,437.0 USD from the U.S. Department of Health & Human Services. | STTR | PHS2001-2 | Phase I | 103,437 | ||||||||
A STTR Phase I contract was awarded to Biostream Therapeutics, Inc. for $295,466.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HD043649-01 | Phase I | 295,466 | ||||||||
A STTR Phase I contract was awarded to Biostream Therapeutics, Inc. for $208,726.0 USD from the U.S. Department of Health & Human Services. | STTR | PHS2001-2 | Phase I | 208,726 | ||||||||
A SBIR Phase I contract was awarded to Biostream Therapeutics, Inc. for $148,922.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL070350-01 | Phase I | 148,922 | ||||||||
A SBIR Phase I contract was awarded to Biostream Therapeutics, Inc. for $185,363.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL070382-01 | Phase I | 185,363 | ||||||||
A SBIR Phase I contract was awarded to Biostream Therapeutics, Inc. for $96,766.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS042965-01 | Phase I | 96,766 | ||||||||
A SBIR Phase I contract was awarded to Biostream Therapeutics, Inc. for $98,125.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 98,125 | |||||||||
A SBIR Phase I contract was awarded to Biostream Therapeutics, Inc. for $98,075.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 98,075 | |||||||||
A SBIR Phase I contract was awarded to Biostream Therapeutics, Inc. for $98,742.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 98,742 | |||||||||
A SBIR Phase I contract was awarded to Biostream Therapeutics, Inc. for $96,513.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 96,513 |
